How Replimune's drug got a third chance after the White House intervened
Replimune(US:REPL) WSJ·2026-05-30 09:53公司动态 - Replimune公司代表在五月初会见了白宫官员 [1] - 美国食品药品监督管理局计划在五月底前重新审查该公司的黑色素瘤药物 [1]
Replimune(US:REPL) WSJ·2026-05-30 09:53Replimune(US:REPL) WSJ·2026-05-30 09:53